Filter
715
Text search:
Good
Manufacturing
Practices
Featured
Recommendations
57
New Publications
194
Language
Document type
No document type
368
Studies & Reports
137
Guidelines
108
Strategic & Response Plan
43
Manuals
33
Fact sheets
9
Training Material
8
Situation Updates
6
Brochures
1
Resource Platforms
1
Videos
1
Countries / Regions
Kenya
34
India
33
Global
25
Uganda
20
Ghana
19
Nigeria
18
Ethiopia
18
Western and Central Europe
16
Sierra Leone
15
Zambia
13
South Africa
13
Nepal
12
Tanzania
12
Liberia
10
Rwanda
10
Africa
10
Philippines
9
South–East Asia Region
8
Zimbabwe
7
Bangladesh
7
Malawi
7
Namibia
7
Ukraine
7
Myanmar / Burma
7
Guinea
6
Indonesia
6
Botswana
5
Lesotho
5
Asia
5
Congo, Democratic Republic of
4
Haiti
4
Syria
4
Cambodia
4
Eswatini/ Swaziland
4
East and Southern Africa
4
West and Central Africa
4
Latin America and the Carribbean
4
Eastern Europe
4
South Sudan
3
Eastern Europe and Central Asia
3
Senegal
2
USA
2
Cameroon
2
Pakistan
2
Thailand
2
Sudan
2
Sri Lanka
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Tajikistan
2
Moldova
2
Mauritius
2
Afghanistan
1
Turkey
1
China
1
Benin
1
Colombia
1
Ecuador
1
Venezuela
1
Russia
1
Australia
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
279
Key Resources
42
Public Health
39
Clinical Guidelines
37
Pharmacy & Technologies
27
Women & Child Health
18
Capacity Building
7
Toolboxes
Pharmacy
69
AMR
62
COVID-19
55
HIV
42
Planetary Health
40
TB
22
Rapid Response
19
Mental Health
19
Ebola
16
Global Health Education
14
Disability
13
Conflict
13
Specific Hazards
11
NCDs
11
Natural Hazards
10
NTDs
8
Health Financing Toolbox
8
Refugee
7
Caregiver
5
Cholera
4
Polio
3
Zika
2
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells
...
PQDx 0179-012-00 WHO
PQDx Public Report
June/2017, version 4.0
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
Public Report
PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
WHO/UNICEF/UNFPA joint statement
Infectious disease outbreaks are periods of
great uncertainty. Events unfold, resources
and capacities that are often limited
are stretched yet further, and decisions
for a public health response must be
made quickly, even though the evidence
for decision-making may be scant. In
such a
...
Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts)
Number: PQDx 0133-045-00
0133-045-00 WHO
PQDx PR
June/2016, version 2.0